Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai ChemPartner Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10840
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, among others. It offers its services in the areas of biologics, chemistry, biology, drug metabolism pharmacokinetic and exploratory toxicology. ChemPartner holds expertise in therapeutic areas of oncology, pathology, neuroscience, tumor immunology, neuroscience, cell biology, epigenetics and metabolic disorders. The organization provides its custom research services to pharmaceutical and biotechnology companies. It has its operations in Denmark, Japan and the US. ChemPartner is headquartered in Pudong, China.

Shanghai ChemPartner Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Berkeley Lights Enters into Co-Development Agreement with Shanghai ChemPartner 11
Link Health Enters into Research Agreement with Shanghai ChemPartner 12
ChemPartner Enters into Co-Development Agreement with Active Motif 13
Merger 14
Shanghai ChemPartner Merges with Quantum Hi-Tech (China) Biological 14
Licensing Agreements 15
Huabobio Enters Into Licensing Agreement With ChemPartner 15
Acquisition 16
Quantum Hi-Tech China Biological to Acquire Shanghai ChemPartner 16
Shanghai ChemPartner Co Ltd – Key Competitors 17
Shanghai ChemPartner Co Ltd – Key Employees 18
Shanghai ChemPartner Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Mar 24, 2017: ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Berkeley Lights Enters into Co-Development Agreement with Shanghai ChemPartner 11
Link Health Enters into Research Agreement with Shanghai ChemPartner 12
ChemPartner Enters into Co-Development Agreement with Active Motif 13
Shanghai ChemPartner Merges with Quantum Hi-Tech (China) Biological 14
Huabobio Enters Into Licensing Agreement With ChemPartner 15
Quantum Hi-Tech China Biological to Acquire Shanghai ChemPartner 16
Shanghai ChemPartner Co Ltd, Key Competitors 17
Shanghai ChemPartner Co Ltd, Key Employees 18
Shanghai ChemPartner Co Ltd, Other Locations 19
Shanghai ChemPartner Co Ltd, Subsidiaries 19

List of Figures
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fanuc Corp (6954)
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Mentor Graphics Corporation:企業の戦略的SWOT分析
    Mentor Graphics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Yokogawa Electric Corporation:戦略・SWOT・企業財務分析
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • Santee Cooper:電力:M&Aディール及び事業提携情報
    Summary Santee Cooper (Santee), formerly South Carolina Public Service Authority, is a state-owned electric and water utility. The company generates the electricity from coal, natural gas, nuclear, hydro, biomass, landfill, and solar sources. It purchases, sells, and exchanges energy with other bulk …
  • Etex Group Sa
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Meritage Midstream Services II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Meritage Midstream Services II LLC (Meritage Midstream), a subsidiary of Howard Midstream Energy Partners LLC, is an oil and gas company that provides midstream services. The company offers natural gas gathering, compression and handling, NGL treating and processing; natural-gas liquids trea …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Naspers Limited:企業の戦略・SWOT・財務分析
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Spherix Inc (SPEX):企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Acesur:企業の戦略・SWOT・財務情報
    Acesur - Strategy, SWOT and Corporate Finance Report Summary Acesur - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Corporate Office Properties Trust:企業の戦略・SWOT・財務情報
    Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report Summary Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Kenya Electricity Generating Co Ltd (KGEN):電力:M&Aディール及び事業提携情報
    Summary Kenya Electricity Generating Co Ltd (KenGen) is an electricity generation utility. It produces power from hydro, geothermal, thermal, and wind sources. Under power purchase agreements, the company sells power to customers on wholesale basis. Kenya Power and Lighting Company Limited is the au …
  • Nitto Boseki Co Ltd:企業の戦略・SWOT・財務情報
    Nitto Boseki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitto Boseki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mainstream Renewable Power Ltd:企業の戦略的SWOT分析
    Mainstream Renewable Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ConvaTec Group Plc (CTEC):企業の財務・戦略的SWOT分析
    ConvaTec Group Plc (CTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆